Daraxonrasib: A New Pill That Could Change the Future of Pancreatic Cancer Treatment
Daraxonrasib is a promising new oral treatment that nearly doubled survival in metastatic pancreatic cancer patients during a Pha…
Evidence-informed articles on chronic pancreatitis, EPI, TPIAT, nutrition, and the tech helping patients live better.
Daraxonrasib is a promising new oral treatment that nearly doubled survival in metastatic pancreatic cancer patients during a Pha…
Tracking pancreatitis symptoms between appointments can help patients identify patterns, improve communication with providers, an…
One of the hardest parts about living with pancreatic disease is not always the pain itself — it’s feeling like nobod…
Most patients think logging a pain score is just checking a box. But to a physician, that data tells a story no office visit ever…
Memorial Day weekend marks the unofficial start of summer — backyard cookouts, family gatherings, cold drinks, and long aft…
If you have pancreatic disease and have been diagnosed with Type 2 diabetes without any of the above being evaluated, it may be w…
When patients with chronic pancreatitis track consistently..." is structured like a direct answer. Consider adding a short bolded…
Most people have never heard of hypertriglyceridemia. Their doctors might not bring it up at the ER. The standard blood panel mig…
Most apps that claim to help with chronic illness tracking were not built with pancreatitis in mind. We reviewed every pancreatit…